Life sciences startup Cora Therapeutics raises C$1m in seed VC

Based in Toronto, Cora Therapeutics is the developer of DNA HALO, an advanced antioxidant formulation.

28 March 2023•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.